NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Attana AB
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Attana Signs Distribution Agreement with Izinta Trading Company Ltd - Attana AB has signed a distribution agreement with Izinta Trading Company Ltd for Hungarian market in the life science sector
Attana Signs Distribution Agreement with Izinta Trading Company Ltd

 

NewswireToday - /newswire/ - Stockholm, Sweden, 2009/03/16 - Attana AB has signed a distribution agreement with Izinta Trading Company Ltd for Hungarian market in the life science sector.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Attana AB, a leading supplier of the next generation biosensor for real time, label-free biosensor systems for molecular interactions studies, has signed a distribution agreement with Izinta Trading Company Ltd. a key distributor of high technology solutions in several life science applications, covering the entire Hungarian market in the life science sector.

Under the terms of agreement, Izinta will commence sales and marketing of Attana’s systems in Hungary beginning March 2009. Commenting on the agreement, Dr. Teodor Aastrup, CEO Attana said, “We are truly delighted to have come to an agreement with Izinta Trading Company Ltd. for coming onboard the distribution of our products. During the past seven years we have improved the Attana systems to be able to build a strong customer base in the European market. This agreement is naturally seen as the next logical step to accelerate our successful sales activities in Europe.”

“We see Attana as an innovative company that produces the next generation biosensor for high quality and high accuracy analysis. This has a unique product offering which complements our current product portfolio in a synergetic way to expand our presence in the market with the Attana biosensor systems,” commented Dr. Mihály Kramer Ph.D., CEO of Izinta.

About Izinta Trading Company Ltd

Izinta Trading Company Ltd. is an important Hungarian distributor company active mostly in the human, and veterinary diagnostic field, as well as in academic and RDbiotech and related research. Izinta’s products offer portfolio includes a wide variety of in vitro diagnostic devices, biochemical / molecular biological reagents, and hi-tech molecular biological instrumentation, among otherss,. veterinary diagnostics and instrumentation , nuclear medicine and their instruments, and basic plastic labware. The mMajor customer groups served by Izinta includes R and D departments of pharmaceutical companies, both human and veterinarian laboratories for basic and applied research laboratories, as well as, and hospital departments in nuclear medicine for surgery and diagnosisclinical and immunological diagnostics labs in hospitals. Incorporated in 1993, Izinta Trading Company Ltd. isoperates under also ISO certified (EN ISO 9001:2000 standards.

ABOUT Attana
Balancing Power and Simplicity in molecular interactions studies
Based in Stockholm, Sweden, Attana AB (attana.com) was founded with the goal of becoming a world leader within the sensor technologies for detecting, registering and measuring chemical and biochemical reactions. Based on the continuous-flow Quartz Crystal Microbalance (QCM) technology for real time, label-free molecular interaction studies, Attana has developed the next generation biosensor for high quality and high accuracy measurements. Attana believes in innovation, dedication, and being customer and solutions oriented in our operations and activities. Our systems have since 2003 been employed at leading universities and biotech companies in a wide variety of research fields within the life sciences in Europe and the USA.

ABOUT the Technology
Quartz Crystal Microbalance (QCM) can be explained as a very sensitive scale or balance capable of measuring atomic changes in mass. By applying an AC-potential to a piezoelectric quartz crystal, it can be controlled to oscillate at its resonance frequency. When molecules are added to, or removed from the surface, the change in the resonance frequency can be converted to a mass response. By immobilizing a specific molecule (the target) to the surface of the crystal and letting a sample flow over the surface, the target’s interaction with the sample can efficiently be studied in real time. The real time information provided can include detail kinetics, affinity, specificity, and active concentration determination data even in crude samples analysis.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Attana AB

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Attana Signs Distribution Agreement with Izinta Trading Company Ltd

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Alexander Kovacs, PhD. - Attana.com 
+46(0)8 410 200 00 alexander.kovacs[.]attana.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Attana AB securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Attana AB / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen’s Global Natural History Study of Fibrodysplasia Ossificans Progressiva Shows Debilitating Impact of the Disease Over An Individual’s Lifetime
BASF and Evonik Partner to Reduce the Environmental Footprint of the Feed and Animal Protein Industries
Rely+On Virkon from LANXESS Effective Against Monkeypox Virus
DSM Completes Acquisition of Prodap
Bruker’s Arxspan Business for Lab Informatics Expands Customer Capabilities by Joining Tetra Partner Network
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-line Monotherapy for Small Cell Lung Cancer
Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-oncology Candidates from Marengo’s STAR Platform
SCHOTT Establishes Stand-alone Company for its Pharma Business to Promote Further Growth
Bushu Pharma Lauded by Frost & Sullivan for Enabling the Launch of Specialty Drugs in Japan and Asia-Pacific
BASF Expands World-scale Vitamin A Formulation Plant in Ludwigshafen
Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients
GenScript ProBio and ProteoNic BV Signed a Strategic Cooperation Based on High Expressing Vector System
Ipsen Receives Positive Opinion in Europe for Dysport® in the Management of Urinary Incontinence in Adults
DSM Acquires Brazil’s Leading Animal Nutrition Technology Company to Boost Precision Services Offering

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Heavenly Culture World Peace Restoration

Visit  Luxury Executive Wellness





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)